Diffuse alveolar damage in BCGosis: A rare complication of intravesical bacillus calmette-guerin therapy for transitional cell carcinoma

Pathology

Volumn 31, Issue 1, 1999, Pages 55-56

  Tan, Lisa ^a   Testa, Gerard ^b   Yung, Teresa ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b BLACKTOWN HOSPITAL   (Australia)

Author keywords

BCGosis; Diffuse alveolar damage

Indexed keywords

BCG VACCINE;

AGED; ARTICLE; AUTOPSY; BLADDER CARCINOMA; CASE REPORT; GRANULOMATOSIS; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; LUNG INJURY; MALE; TRANSITIONAL CELL CARCINOMA;

EID: 0033048156     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130299105566     Document Type: Article

References (14)

1. Kesten S, Title L, Mullen B, Grossman R. Pulmonary disease following intravesical BCG treatment. Thorax 1990; 45: 709-10.
2. Moss JT, Kadmon D. BCG and the treatment of superficial bladder cancer. DICP: Ann Pharmacother 1991; 25: 1355-66.
3. Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992; 147: 596-600.
4. Morales A. Long-term results and complications of intracavitary bacillus Calmette-Guérin therapy for bladder cancer. J Urol 1984; 132: 457-9.
5. Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of bacillus Calmette-Guérin immunotherapy in 1278 patients with bladder cancer. J Urol 1986; 135: 272-4.
6. Orihuela E, Herr HW, Pinsky CM, Whitmore WF. Toxicity of intravesical BCG and its management in patients with superficial bladder cancer. Cancer 1987; 60: 326-33.
7. Steg A, Sicard D, Leleu C, DeBre B, Boccon-Gibod L. Systemic complications of intravesical BCG therapy for bladder cancer. Lancet 1985; ii: 899.
8. Steg A, Leleu C, DeBre B, Boccon-Gibod L, Sicard D. Systemic BCG infection, "BCGitis" in patients treated by intravesical BCG therapy for bladder cancer. J Eur Urol 1989; 16: 161-4.
9. Gupta RC, Lavengood R, Smith JP. Miliary tuberculosis due to intravesical bacillus Calmette-Guérin therapy. Chest 1988; 94: 1296-8.
10. Skoutelis A, Melekos MD, Bassaris HJ. Miliary tuberculosis secondary to transurethral bacillus Calmette-Guérin administration for superficial transitional cell carcinoma of the bladder. J Natl Cancer Inst 1990; 82: 1219-20.
11. Smith RL, Alexander RF, Aranda CP. Pulmonary granulomata. A complication of intravesical administration of bacillus Calmette-Guérin for superficial bladder carcinoma. Cancer 1993; 71: 1846-7.
12. van der Meidjen APM, Debruyne FMJ, Steerenberg PA, de Jong WH. Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview. Prog Clin Biol Res 1989; 310: 11-33.
13. Katzenstein A-L A, Askin FB. Surgical pathology of non-neoplastic lung disease. 2nd edn. Philadelphia: WB Saunders Company, 1990: 10-34.
14. Yoshida N, Ejiri M, Yasumoto K, Fujita M, Sasayama S. Adult respiratory distress syndrome in a patient with uncomplicated acute myocardial infarction. Jpn Circ J 1992; 56(12): 1253-6.